Cargando…
An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma
The aim of the present study was to optimize a chromatographic method for the analysis of atorvastatin (acid and lactone forms), ortho- and para-hydroxyatorvastatin by using an experimental design approach. Optimization experiments were conducted through a process of screening and optimization. The...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270013/ https://www.ncbi.nlm.nih.gov/pubmed/23439563 http://dx.doi.org/10.3390/molecules18032469 |
_version_ | 1783376600366055424 |
---|---|
author | Crevar-Sakač, Milkica Vujić, Zorica Brborić, Jasmina Kuntić, Vesna Uskoković-Marković, Snežana |
author_facet | Crevar-Sakač, Milkica Vujić, Zorica Brborić, Jasmina Kuntić, Vesna Uskoković-Marković, Snežana |
author_sort | Crevar-Sakač, Milkica |
collection | PubMed |
description | The aim of the present study was to optimize a chromatographic method for the analysis of atorvastatin (acid and lactone forms), ortho- and para-hydroxyatorvastatin by using an experimental design approach. Optimization experiments were conducted through a process of screening and optimization. The purpose of a screening design is to identify the factors that have significant effects on the selected chromatographic responses, and for this purpose a full 2(3) factorial design was used. The location of the true optimum was established by applying Derringer’s desirability function, which provides simultaneously optimization of all seven responses. The ranges of the independent variables used for the optimization were content of acetonitrile in mobile phase (60–70%), temperature of column (30–40 °C) and flow rate (0.8–1.2 mL min(−1)). The influences of these independent variables were evaluated for the output responses: retention time of first peak (p-hydroxyatorvastatin) and of last peak (atorvastatin, lactone form), symmetries of all four peaks and relative retention time of p-hydroxyatorvastatin. The primary goal of this investigation was establishing a new simple and sensitive method that could be used in analysis of biological samples. The method was validated and successfully applied for determination of atorvastatin (acid and lactone forms) and its metabolites in plasma. |
format | Online Article Text |
id | pubmed-6270013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62700132018-12-20 An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma Crevar-Sakač, Milkica Vujić, Zorica Brborić, Jasmina Kuntić, Vesna Uskoković-Marković, Snežana Molecules Article The aim of the present study was to optimize a chromatographic method for the analysis of atorvastatin (acid and lactone forms), ortho- and para-hydroxyatorvastatin by using an experimental design approach. Optimization experiments were conducted through a process of screening and optimization. The purpose of a screening design is to identify the factors that have significant effects on the selected chromatographic responses, and for this purpose a full 2(3) factorial design was used. The location of the true optimum was established by applying Derringer’s desirability function, which provides simultaneously optimization of all seven responses. The ranges of the independent variables used for the optimization were content of acetonitrile in mobile phase (60–70%), temperature of column (30–40 °C) and flow rate (0.8–1.2 mL min(−1)). The influences of these independent variables were evaluated for the output responses: retention time of first peak (p-hydroxyatorvastatin) and of last peak (atorvastatin, lactone form), symmetries of all four peaks and relative retention time of p-hydroxyatorvastatin. The primary goal of this investigation was establishing a new simple and sensitive method that could be used in analysis of biological samples. The method was validated and successfully applied for determination of atorvastatin (acid and lactone forms) and its metabolites in plasma. MDPI 2013-02-25 /pmc/articles/PMC6270013/ /pubmed/23439563 http://dx.doi.org/10.3390/molecules18032469 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Crevar-Sakač, Milkica Vujić, Zorica Brborić, Jasmina Kuntić, Vesna Uskoković-Marković, Snežana An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma |
title | An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma |
title_full | An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma |
title_fullStr | An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma |
title_full_unstemmed | An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma |
title_short | An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma |
title_sort | improved hplc method with the aid of a chemometric protocol: simultaneous determination of atorvastatin and its metabolites in plasma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270013/ https://www.ncbi.nlm.nih.gov/pubmed/23439563 http://dx.doi.org/10.3390/molecules18032469 |
work_keys_str_mv | AT crevarsakacmilkica animprovedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma AT vujiczorica animprovedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma AT brboricjasmina animprovedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma AT kunticvesna animprovedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma AT uskokovicmarkovicsnezana animprovedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma AT crevarsakacmilkica improvedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma AT vujiczorica improvedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma AT brboricjasmina improvedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma AT kunticvesna improvedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma AT uskokovicmarkovicsnezana improvedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma |